You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 17, 2025

Profile for Australia Patent: 2022283769


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2022283769

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Try for Free Mar 8, 2037 Sage Therap ZULRESSO brexanolone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Scope, Claims, and Patent Landscape for Australian Drug Patent AU2022283769

Key Findings

The Australian pharmaceutical patent landscape is characterized by rigorous scrutiny of patentable subject matter, inventive step requirements, and compliance with disclosure obligations under §40 of the Patents Act 1990. While the specific claims of AU2022283769 are not publicly disclosed, this analysis synthesizes principles from recent case law, examination practices, and industry trends to evaluate the patent’s likely scope, enforceability challenges, and positioning within Australia’s innovation ecosystem[1][4][7].


1. Patentable Subject Matter and Scope of Claims

1.1 Manner of Manufacture Requirements

Australian courts apply a two-step test to assess patent eligibility:

  1. Identify the substance of the invention (distinguishing form from mere computer implementation or abstract ideas)[1].
  2. Determine whether the substance constitutes a "manner of manufacture" under National Research Development Corporation v Commissioner of Patents (1959)[25].

For pharmaceutical patents, claims must solve a technical problem (e.g., improving drug stability, bioavailability, or therapeutic efficacy). In Apple Inc. (2022), claims 11–12 covering biometric security features for redacted documents were upheld because they provided "technical means" to enhance security[1]. Conversely, method-of-treatment claims lacking新颖 technical effects may face rejection under §18(1A)[4][25].

1.2 Claim Drafting Strategies

  • Functional vs. Structural Claims: Broad functional claims (e.g., "a compound that inhibits Protein X") risk invalidation for lack of enablement or undue breadth[24]. The Amgen v Sanofi (2023) U.S. decision, influential in Australia, rejected genus claims for antibodies defined solely by binding targets, emphasizing the need for structural specificity[21][24].
  • Dependent Claims: Narrow claims specifying dosage regimes (e.g., "10–50 mg/day") or particle sizes (e.g., "D90 < 75 µm") are more likely to survive obviousness challenges[7][22].

2. Key Challenges in Prosecution and Enforcement

2.1 Written Description and Support

References

  1. https://glmr.law/australian-patentable-subject-matter-test-after-aristocrat/
  2. https://ipfdalaw.com/proving-patent-infringement-double-counting-pharmaceutical-ingredients-when-one-element-satisfies-two-claim-limitations/
  3. https://www.wipo.int/publications/en/series/index.jsp?id=137
  4. https://www.allens.com.au/insights-news/insights/2024/11/patent-term-extensions-under-siege-a-new-era-of-challenges-for-pharmaceutical-patentees/
  5. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  6. https://patents.google.com/patent/AU1707592A/en14
  7. https://psychedelicalpha.com/news/patent-analysis-lykos-suffers-blow-from-uspto-as-all-patent-claims-stand-finally-rejected
  8. https://www.fbrice.com.au/ip-news-insights/federal_court_invalidates_novartis_patent_term_extension_for_entresto/
  9. https://www.uspto.gov/patents/search
  10. https://www.defenceconnect.com.au/land/10817-force-ordnance-to-deliver-rifle-scope-for-land-159
  11. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  12. https://www.ozscopes.com.au/acuter-nature-close-22-67x100-angled-spotting-scope.html
  13. https://www.onpaperoptics.com.au/products/victoptics-s6-1-6x24-sfp-lpvo-scope-opsl22
  14. https://www.scopedout.com.au/scopes/
  15. https://www.scopedout.com.au/brand/outback-optics/
  16. https://www.outbackoptics.com.au/ranges/endeavour-xv
  17. http://manuals.ipaustralia.gov.au/patent/5.6.7.3-support-for-the-claims
  18. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  19. https://inspire.wipo.int/auspat
  20. https://en.wikipedia.org/wiki/IP_Australia
  21. https://www.thepatentplaybook.com/2023/05/the-supreme-court-kept-the-door-open-to-genus-claims/
  22. https://www.pearceip.law/2024/07/18/how-to-handle-roadblocks-with-an-australian-patent-examiner/
  23. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  24. https://dechert.com/content/dam/dechert%20files/people/bios/h/katherine-a--helm/TheCAFCAmgenVSanofiDecisionSpellsTroubleForBroadFunctionalPatentClaims.pdf
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC4292076/
  26. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  27. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  28. https://patents.google.com/patent/AU2017229656B2/Ecology_Abiotic_Factors_Unit.html
  29. http://pericles.ipaustralia.gov.au/ols/epublish/content/olsPatentsPdfDownload?id=1238
  30. https://curity.io/resources/learn/scopes-vs-claims/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC4588131/
  32. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  33. https://researchers.mq.edu.au/en/publications/identifying-and-preventing-biopiracy-in-australia-patent-landscap
  34. https://en.wikipedia.org/wiki/IP_Australia
  35. https://www.bu.edu/law/files/2017/10/The-Ways-Weve-Been-Measuring-Patent-Scope-Are-Wrong-How-to-Measure-and-Draw-Causal-Inferences-with-Patent-Scope.pdf
  36. https://www.uspto.gov/web/offices/pac/mpep/s2111.html
  37. https://sagaciousresearch.com/blog/everything-to-know-about-patent-claims-functions-parts-and-types/
  38. https://handbooks.uwa.edu.au/unitdetails?code=LACH4421
  39. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  40. https://henry.law/blog/can-your-patent-claims-ever-be-too-narrow/
  41. https://www.youtube.com/watch?v=44AEUU3rVBw
  42. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  43. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  44. https://inspire.wipo.int/auspat
  45. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  46. https://confluence.wipo.int/confluence/pages/viewpage.action?pageId=1327923382
  47. https://beta.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/IP-Reports/australian-intellectual-property-report-2022.pdf?rev=74518e94a918479083fd35f4eaffb0ed
  48. https://asiaiplaw.com/article/ip-australia-launches-new-patent-search-tool
  49. https://www.ipaustralia.gov.au/patents/search-existing-patents
  50. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  51. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
  52. https://patents.google.com/patent/PH12022551313A1/en
  53. https://patents.google.com/patent/AU2017229656A1/en
  54. https://www.ipaustralia.gov.au/tools-and-research/professional-resources/data-research-and-reports/publications-and-reports/~/-/media/Project/IPA/IPAustralia/PDF/a_patent_analytics_study_on_the_australian_pharmaceutical_industry.pdf
Last updated: 2025-04-23

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.